CPIG
AXSM icon

Chicago Partners Investment Group’s Axsome Therapeutics AXSM Stock Holding History

Chicago Partners Investment Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,663
Closed -$263K – 571
2021
Q3 		$263K Buy
+6,663
New +$260K 0.02% 473
2021
Q2 		– Sell
-3,569
Closed -$210K – 535
2021
Q1 		$210K Buy
3,569
+853
+31% +$60K 0.02% 481
2020
Q4 		$203K Buy
+2,716
New +$203K 0.02% 438

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chicago Partners Investment Group's AXSM Position: Q4 2021 in Review

Chicago Partners Investment Group sold out of Axsome Therapeutics (AXSM) in Q4 2021, closing a stake of 6,663 shares — an estimated $263K sold.

Chicago Partners Investment Group first reported a position in AXSM in Q4 2020 and held it in 3 quarters. The position peaked at $263K in Q3 2021. 167 funds tracked by Wall St. Rank hold AXSM as of Q4 2021.

  • Chicago Partners Investment Group reported no remaining Axsome Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Chicago Partners Investment Group sold 6,663 Axsome Therapeutics shares in Q4 2021, an estimated $263K.
  • Chicago Partners Investment Group first reported a position in Axsome Therapeutics in Q4 2020 and held it in 3 quarters.
  • Chicago Partners Investment Group's Axsome Therapeutics position peaked at $263K in Q3 2021.
  • 167 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2021.

Based on Chicago Partners Investment Group's 13F filing for Q4 2021, filed 15 Feb 2022.